Company: SYRA
Filing Date: 2025-06-17
Form Type: 8-K
Source: 0001641172-25-015349
Chunk: 0

Company: Syra Health Corp
Filing Date: 2025-06-17
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item
5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
of Certain Officers.

On
June 13, 2025, the Board of Directors of Syra Health Corp. (the “ Company”) approved the termination for cause of the employment
agreement between Deepika Vuppalanchi, the Company’s CEO, and the Company dated April `5, 2021, as amended.

On
June 16, 2025, the Board of Directors of the Company appointed Priya Prasad, the Company’s CFO and COO, as interim CEO.

   2  

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

                     SYRA                                       
  Date:              By:               /s/                      
                                       Priya                    

   3